Asim Abdel-Mageed, DVM, MS, PhD


Academic Office – (504) 988-3634
Fax: (504) 988-5059


Dr. Abdel-Mageed is a Professor of Urology at Tulane University School of Medicine, the Director of Molecular Oncology Research at Tulane University Health Sciences Center, the Zimmermann Endowed Professor of Cancer Research at the Tulane Cancer Center, and an adjunct professor in the Department of Pharmacology, the Center for Stem Cell Research and Regenerative Medicine, and the Graduate Program in Biomedical Sciences at Tulane. A former practicing veterinarian, he received his D.V.M. from the University of Khartoum in Sudan (1983), his M.S. (1989) and Ph.D. (1993) in Molecular Physiology and Toxicology from Kansas State University. Upon completing his postdoctoral fellowship in Tulane’s Department of Pharmacology (1994), he became a research instructor of pharmacology in 1996, subsequently joining the Department of Urology in 1997.

With a broad background in cancer research encompassing molecular and cellular biology and therapeutic approaches using in vitro and in vivo model systems, Dr. Abdel-Mageed and his research program have been continuously supported since 1997 by multiple grants from the National Cancer Institute (NCI), the National Center for Advancing Translational Sciences (NCATS), the National Institutes of Health (NIH), the US Department of Defense (DOD), and the American Cancer Society (ACS). Having received numerous awards during his academic career, including the American Association for Cancer Research Scholar Award, his research is marked by over 95 peer-reviewed publications and over 100 presentations at national and international meetings. While his long-standing translational research interests focus on molecular determinants of prostate cancer progression and prostate cancer health disparities, his current research also focuses on understanding the role of tumor-derived exosomes in mediating prostate cancer progression, with special emphasis on racial disparity of prostate cancer. Importantly, his research recently identified that lead compounds, via high-throughput strategies, can be repurposed to effectively target and inhibit exosome biogenesis/secretion and uptake by recipient cells.

Since his tenure at Tulane University School of Medicine, Dr. Abdel-Mageed has mentored over 50 graduate students, postdoctoral fellows, junior faculty members, and international scholars. In addition to his mentoring, researching, and teaching, he is a member of the NIH Steering Committee for the Extracellular RNA Communication Consortium (ERCC), the Vesicle Isolation and Function (VIF) subgroup of the ERCC, the NIH/TME Study Section, and the Internal Coordinating Committee for the NIH/NCI/Geographic Management of Cancer Health Disparities Programs (GMaP). Furthermore, he has served on numerous national and international study sections and review panels, including the ASC, DOD, NIH, Italian Academy of Sciences, Qatar National Foundation, and Singapore Medical Research Council.